Message Font: Serif | Sans-Serif
No. of Recommendations: 2

Gilead's Got Cash Up to the Gills
By John Bluis
April 19, 2006

Gilead Sciences (Nasdaq: GILD) celebrated its ninth straight quarter of beating analyst estimates, trouncing its year-ago results even after the newly added expensing of stock-based compensation costs. Diluted EPS rose 61.7% to $0.55, compared to the $0.34 in the first quarter of 2005. I also calculated -- for your convenience -- a 73.5% increase in diluted EPS without stock-based compensation costs of $0.04 per diluted share.....
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.